There are numerous studies supporting the role of leptin and its receptor in the development and progression of breast cancer [31]. The first step to clarify the situation in our study group was to establish a correlation between the indicators of obesity and the serum level of leptin. This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.